P021 Characteristics of Patients Treated with Tofacitinib for Ulcerative Colitis in the Real World: Findings from a Large US Claims Database.

Autor: Michael C; Virginia Mason Hospital, Seattle, United States., Puza S; Pfizer Inc, New York City, United States., Benjamin C; Optum, Eden Prairie, United States., Leonardo S; Pfizer, Inc., Collegeville, United States., Elizabeth B; Optum, Eden Prairie, United States., Jesse PB; Optum, Eden Prairie, United States., Joseph C; Pfizer, Inc., Groton, United States., Xiang G; Pfizer, Inc., Collegeville, United States., Nabeel K; University of Pennsylvania School of Medicine, Philadelphia, United States.
Jazyk: angličtina
Zdroj: The American journal of gastroenterology [Am J Gastroenterol] 2020 Dec 01; Vol. 115 (Suppl 1), pp. S5-S6.
DOI: 10.14309/01.ajg.0000722880.82318.b8
Databáze: MEDLINE